Monday, December 23, 2024
HomeTagsATA-100

ATA-100

Atamyo Therapeutics Announces Significant Milestones for ATA-100 and ATA-200, its Gene Therapy Programs to Treat Limb-Girdle Muscular Dystrophy 2I/R9 and 2C/R5

Atamyo Therapeutics, a biotechnology company focused on the development of new-generation gene therapies targeting neuromuscular diseases, announced multiple major milestones for ATA-100 and ATA-200,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics